Compounded vs Branded GLP-1
One is FDA-approved; the other is compounded by a 503A pharmacy. Here is what changes between them — and what to weigh.
Compounded semaglutide and tirzepatide are prepared by 503A compounding pharmacies. Unlike the branded versions, compounded preparations are not FDA-approved and are not FDA-approved generics or equivalents; the supply chain, pricing, dosing flexibility, and regulatory pathway all differ.
Side by side.
Who picks which.
- No insurance coverage for branded GLP-1s
- Want custom dosing (e.g. micro-doses, slower titration)
- Comfortable with 503A compounded medications under physician oversight
- Have insurance coverage for Wegovy or Zepbound
- Prefer FDA-approved supply chain regardless of cost
- Want fixed-dose pens, not vials and syringes
If your insurance covers a branded option, take it — the supply chain and dosing simplicity are real benefits. If it doesn't, compounded medication from a LegitScript-verified pharmacy under physician oversight is a lower-cost option, though it is not FDA-approved. Your clinician can advise whether it fits your situation.
See if I qualifyPrescription treatments require an online visit reviewed by a U.S.-licensed provider, who determines if a treatment is clinically appropriate. Compounded medications are prepared by licensed U.S. pharmacies and are not FDA-approved. Individual results vary.